Paolo Cionini - Almirall Chief Board

ALM Stock  EUR 8.74  0.07  0.81%   

Insider

Paolo Cionini is Chief Board of Almirall SA
Phone34 93 291 30 00
Webhttps://www.almirall.com

Almirall Management Efficiency

The company has return on total asset (ROA) of 0.0204 % which means that it generated a profit of $0.0204 on every $100 spent on assets. This is way below average. Almirall's management efficiency ratios could be used to measure how well Almirall manages its routine affairs as well as how well it operates its assets and liabilities.
Almirall SA has accumulated 363.5 M in total debt with debt to equity ratio (D/E) of 0.35, which is about average as compared to similar companies. Almirall SA has a current ratio of 2.28, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Almirall until it has trouble settling it off, either with new capital or with free cash flow. So, Almirall's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Almirall SA sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Almirall to invest in growth at high rates of return. When we think about Almirall's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Mikel LandnCIE Automotive SA
61
Santiago AretaCIE Automotive SA
75
Steven JDGrifols SA
63
Fernando GarijoLaboratorios Farmaceuticos ROVI
N/A
Jesus EsmorisCIE Automotive SA
59
Alfredo GuerraGrifols SA
65
Susana ApellanizCIE Automotive SA
53
Rosario PrezLaboratorios Farmaceuticos ROVI
N/A
Montserrat LlamasGrifols SA
58
David BellGrifols SA
69
Pablo GarzonAcerinox
N/A
Jesus BarandiaranCIE Automotive SA
56
Alfonso MaesoCIE Automotive SA
78
Raimon RouraGrifols SA
59
M PerezLaboratorios Farmaceuticos ROVI
N/A
Carlos LoraTamayoAcerinox
N/A
Hans HelmrichAcerinox
52
Irene AlvarezENCE Energa y
N/A
Faustino RodriguezENCE Energa y
N/A
Vctor DeuGrifols SA
46
Francisco GarcaLaboratorios Farmaceuticos ROVI
N/A
Almirall, S.A., a pharmaceutical company, engages in the research, development, manufacture, and sale of skin-health related medicines worldwide. Almirall, S.A. was founded in 1943 and is headquartered in Barcelona, Spain. ALMIRALL S operates under Pharmaceuticals And Biosciences classification in Spain and is traded on Madrid SE C.A.T.S.. It employs 1787 people. Almirall SA (ALM) is traded on Madrid Exchange in Spain and employs 1,786 people.

Management Performance

Almirall SA Leadership Team

Elected by the shareholders, the Almirall's board of directors comprises two types of representatives: Almirall inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Almirall. The board's role is to monitor Almirall's management team and ensure that shareholders' interests are well served. Almirall's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Almirall's outside directors are responsible for providing unbiased perspectives on the board's policies.
Georgia GarinoisMelenikiotou, Independent Director
Antonio Torrededia, Director
Francesca Wuttke, Chief Digital Officer
Esteve Conesa, Senior Vice President of Human Resources
Karl Ziegelbauer, CSO RD
Gerhard Mayr, Independent Director
Eloi Cervera, Vice President - Manufacturing & Technical Services
Pablo Alvarez, President and GM - US
Peter Guenter, Chief Executive Officer, Executive Director
Enrique Perez, Independent Director
Esteve Panicot, VP Board
Carlos Piqu, Interim Board
Bhushan Hardas, Chief Scientific Officer y Executive Vice President Research and Development
Michael McClellan, Chief Financial Officer, Executive Vice President - Finance
Thomas McKillop, Independent Vice Chairman of the Board
Karin Dorrepaal, Independent Director
Jordi Richer, Senior Vice President - Corporate Development
Amita Kent, Senior Vice President Legal, Global Chief Compliance & Data Privacy Officer
Jose Sala, Non-Member Secretary of the Board
Alfredo Juan, Executive Vice President - Global Commercial Operations
Paolo Cionini, Chief Board
Carlos Pique, Director
Jorge Ballart, Chairman of the Board
Volker Koscielny, Chief Medical Officer
Seth Orlow, Independent Director
Joan Carreras, Vice Secretary (non-member) General Counsel

Almirall Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Almirall a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Almirall Stock

Almirall financial ratios help investors to determine whether Almirall Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Almirall with respect to the benefits of owning Almirall security.